Apnimed Inc (APMD) Price Prediction & ForecastAPMDApnimed Inc

While Apnimed has shown significant financial improvement with a net income of $125.93 million for Q2 2026 and an EPS of $3.89, the current RSI of 34.055 indicates it is oversold, suggesting potential for recovery. However, the stock has recently declined by 4.10% over the last five days and is facing regulatory risks with the upcoming FDA decision on February 28, 2027, which could impact its valuation.

Apnimed Inc (APMD) last closed at $18.51, gaining +11.54%. These facts feed the 1-day and 1-week APMD price prediction above.